Openbookopenbook
Equity
MDH
+0.0 · +0.00%
GBX · LSE

Mendell Helium plc(MDH) Stock Analysis | Healthcare

GBX --+0.00%
Reward52Moderate
Risk46Moderate
75%Data
Profitless Growth
Market Cap:18.06M
ⓘ
Reward Rating
52
Moderate
Reward Assessment
75% data coverage
Bottom 50% of stocksView factors
ⓘ
Risk Rating
46
Moderate
Risk Assessment
6 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on MDH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for MDH, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Mendell Helium plc?

Mendell Helium plc engages in the production of helium in the United States.

MDH · Verdict

Moderate reward · moderate risk

MDH stands out on volatility and growth, but watch the cash flow signal.

Based on 88% data coverage

MDH · Verdict

What’s working & what to watch

Strengths 2

  • Volatility75/100

    Above average

  • Growth72/100

    Rev +5867.4% CAGR · earnings +16.6%

Watchouts 2

  • Cash flow7/100

    -323% free-cash-flow margin

  • Profitability9/100

    -408% net margin · -94% ROE

Model-based scoring. For information only — not financial advice.

What is Mendell Helium plc?

Mendell Helium plc engages in the production of helium in the United States. It holds interest in the Fort Dodge Prospect located in Ford County, Kansas; and various wells in its Hugoton North Play project located in Garden City in south-western Kansas. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 18.06M.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (52)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.

PXSNano Cap / 27.3M market cap
Provexis plc
Compare
STXNano Cap / 46.5M market cap
Shield Therapeutics plc
Compare
EAHNano Cap / 67.4M market cap
Eco Animal Health Group Plc
Compare
Company Information
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap18.06M
P/E RatioN/A
Dividend YieldN/A
Beta-0.311
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.